1430494
Last Update Posted: 2015-04-23
Recruiting has ended
All Genders accepted | 12 Years-70 Years |
3409 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
To collect characteristics of patients with ADPKD across a broad population, over time to better understand disease progression (signs, symptoms and outcomes). Association with total kidney volume changes and other measures of disease progression will be determined in order to identify a population at increased risk for disease progression. The economic and quality life impact of ADPKD will be assessed. Subjects who terminated participation early from clinical trials with tolvaptan may also be followed.
Eligibility
Relevant conditions:
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov